TrialAlzheimer's research & therapy2024

Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer's disease, positive for plasma p-tau217.

Branislav Kovacech et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.